To investigate the therapeutic potential of 6F01 mAb in the animal model of autoimmunity, the experimental autoimmune encephalomyelitis (EAE) mice were treated with 6F01 mAb three times a week, and the treatment with anti-IL-17A mAb was used as a positive control. This evidence concerns the gene IL17A and Autoimmunity.